Table 4.
Species (Exposure Route) |
Dose, Duration | Lipid Peroxidation | Non-Enzymatic Antioxidant | Enzymatic Antioxidant Activity | Other Oxidative Stress or Damage Measure | Reference | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
SOD | CAT | GPx/GR | |||||||||
Mouse (oral) |
1.9, 19, 95 mg/kg, 12, 24, 48, 72, 96 h |
1MDA: 1.9 = unaffected; 19 = 1.6x incr after 72h; 95 = 3.2x incr after 48h |
N/A | N/A | N/A | N/A | N/A | Bagchi et al., 2002 | |||
Mouse (d.w.) |
25 mg/kg, 3 d |
TBARS incr 29% | α-tocopherol decr 32% | Vit E and C unaffected | Incr 65% | Incr 74% | GPx unaffected | Travacio et al., 2000 | |||
Mouse (oral) |
25 mg/kg, 6 wk |
MDA incr 1.92x | GSH decr 58% | N/A | N/A | GR decr 55% | Protein carbonyl incr 2x | Abu Zeid, 2018 | |||
Rat (d.w.) |
100 ppm (11.6 mg Cr/kg/d), 30 d |
MDA incr: HT = 30% AP = 65% |
N/A | Incr 2x in AP | Unaffected | GR incr 2x in HT; GPx unaffected |
N/A | Nudler et al., 2009 | |||
Rat (d.w.) |
700 ppm, 21 d |
MDA incr: CTX = 1.2x CB = 94% |
GSH decr: CTX = 52% CB = 15% |
NPSH decr: CTX = 37% CB = 46% |
Vit C decr: CTX = 56% CB = 53% |
N/A | N/A | N/A | Soudani et al., 2012 | ||
Rat (oral) |
0.5 or 2 mg/kg, 24 h, 7 d, 14 d |
MDA incr: 24 h = unaffected 7 d (2 mg/kg) = 4x 14 d = 6.7x, 9.3x |
GSH decr: 24 h = 40%, 70% 7 d = 53%, 76% 14 d = 88%, 95% |
SOD: 24 h = Unaffected, 1.8x incr 7 d = unaffected, 33% decr 14 d = 50%, 75% decr |
N/A | N/A | N/A | Fatima et al., 2017 | |||
Rat (i.p.) |
2 mg/kg, 30 d |
MDA incr 2.5x (CTX) | GSH decr 30% | Decr 50% | N/A | GPx decr 40% | NO incr 1.8x (CTX) | Mahmoud and El-Twab, 2017 | |||
Rat (oral) |
10 mg/kg, 2 wk |
MDA incr 1.9x | GSH unaffected | Nonsig decr 23% | Nonsig decr 42% | N/A | N/A | Sarica et al., 2019 | |||
Rat (i.p.) |
15 mg/kg, 24 h |
Plasma MDA incr 88% | N/A | Unaffected | Unaffected | Both unaffected; GPx non-significant 33% decr | N/A | García-Niño et al., 2015 | |||
Rat (i.n.) |
0.5, 1.0, 2.0 mg/kg, 24 h |
MDA incr: 0.5 = 1.21x 1.0 = 1.61x 2.0 = 2.21x |
GSH decr: 1 = 88% 2 = 75% |
N/A | Decr: 1.0 = 72% 2.0 = 30% |
N/A | N/A | Salama et al., 2016 | |||
Rat (i.p.) |
15 mg/kg, 24 h |
MDA +67% | GSH decr 42% | Non-protein thiols decr 36% | Unaffected | Decr 33% | GR decr 25% | Iztleuov et al., 2018 | |||
Zebrafish (water) | 2 mg/L, 1, 7, 15, 30, 60d |
MDA incr 1.77x on day 15 | GSH incr 1.33x on day 60 | N/A | 15d = 1.58x 30d = 2.58x 60d = 2.35x |
N/A | N/A | Shaw et al., 2020 | |||
Rat (i.n.) |
0.125, 0.25, 0.5 mg/kg/d, 2 weeks | MDA incr: 0.125 = 1.23x 0.250 = 1.77x 0.500 = 2.65x |
GSH decr: 0.125 = 18% 0.250 = 40% 0.500 = 42% |
N/A | N/A | N/A | N/A | Hegazy et al., 2021 | |||
0.125, 0.25, 0.5 mg/kg/d, 1 month | MDA incr: 0.125 = 4.34x 0.250 = 7.70x 0.500 = 7.98x |
MDA incr: 0.125 = 45% 0.250 = 52% 0.500 = 52% |
N/A | N/A | N/A | N/A | |||||
0.125, 0.25, 0.5 mg/kg/d, 2 months | MDA incr: 0.125 = 7.31x 0.250 = 8.00x 0.500 = 8.21x |
MDA incr: 0.125 = 54% 0.250 = 55% 0.500 = 59% |
N/A | N/A | N/A | N/A |
Nota Bene: Data was adjusted to percent of control based on reported mean values.
N/A = not assessed; CTX = cortex/cerebrum; CB = cerebellum; HT = hypothalamus; AP = anterior pituitary; i.p. = intra peritoneal; d.w. = drinking water
Data reflect largest observed effect